ALC vs BNTX
Alcon Inc vs BioNTech SE — AI-powered side-by-side comparison
| Metric | ALC | BNTX |
|---|
| AI Score |
68
|
66
|
| Price |
$75.39
|
$92.76
|
| P/E Ratio |
45.39×
|
-11.76×
|
| ROE |
4.4%
|
-5.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
68.9%
|
| Debt / Equity |
0.24×
|
0.02×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
54.0
|
| Beta |
0.703
|
1.278
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus BNTX.
ALC leads by 2 points.
ALC scores 68/100 (Buy) versus BNTX at 66/100 (Buy).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
BNTX Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro